On April 14-15, 2021, CHERISH Director Bruce Schackman and CHERISH Methodology Core Director Kathryn McCollister participated in the National Ending the HIV Epidemic (EHE) virtual meeting to provide an overview of economic analyses for HIV implementation research. Watch the full recording here.
Dr. Schackman will describe types of health economics research relevant to substance use disorders and co-occurring conditions, how health economics can be incorporated into clinical trials of screening and treatment interventions, and how health economics researchers can collaborate with substance use disorder researchers conducting observational and implementation studies. Examples will be drawn from Dr. Schackman’s recent and ongoing collaborations related to opioid use disorder treatment and to screening and care for HIV and HCV in substance use treatment settings.
This post originally appeared on the Dartmouth Center for Technology and Behavioral Health Seminar Series page.
CHERISH director Dr. Schackman presents research on economic evaluations of screening and linkage to care interventions.
On Tuesday, November 10, 2015, Dr. Benjamin P. Linas, assistant professor of medicine at the Boston University School of Medicine, presented “Understanding access to HCV therapy in 2015” as part of the HepCure Tele-Education Webinar Series.